Advertisement

Übersichtstabellen

  • O. Dietmaier
  • G. Laux

Zusammenfassung

In diesen Tabellen sind die in Deutschland (D), Österreich (A) und der Schweiz (CH) im Handel erhältlichen Antiepileptika, Psychostimulanzien, Beta-Rezeptorenblocker und sonstigen Psychopharmaka alphabetisch nach ihren gebräuchlichen Kurzbezeichnungen aufgeführt. Es wurden die in der Roten Liste 1992 verwandten internationalen Freinamen (INN), INNv (vorgeschlagene Freinamen) oder sonstige Kurzbezeichnungen gewählt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahrens R (1991) Androcur (Cyproteronacetat) bei Sexualdelinquenz — Nachuntersuchung von untergebrachten psychiatrischen Patienten. Schweiz Arch Neurol Psychiat 142: 171–188Google Scholar
  2. Ananth J, Lin KM (1986) Propranolol in psychiatry. Neuropsychobiology 15: 20–27PubMedCrossRefGoogle Scholar
  3. Baruzzi A, Michelucci R, Tassinari CA (1989) Nitrazepam. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 785–804Google Scholar
  4. Booker HE (1989) Trimethadione. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 715–720Google Scholar
  5. Browne TR (1989) Methsuximide. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 707–714Google Scholar
  6. Chaturvedi SK (1985) Metoprolol: a new selective beta blocker in anxiety neurosis. Psychopharmacology 85: 488PubMedCrossRefGoogle Scholar
  7. Clarenbach P, Fröscher W (1986) Indikationen der Benzodiazepin-Antikonvulsiva. In: Hippius H, Engel RR (Hrsg) Therapie mit Benzodiazepinen — Rückblick und Ausblick. Springer, Berlin Heidelberg New York Tokyo, S 195–200Google Scholar
  8. Dren AT, Janicki RS (1977) Pemoline. In: Goldberg ME (ed) Pharmacological and biochemical properties of drug substances. American Pharmaceutical Association, Washington, pp 33–65Google Scholar
  9. Eadie MJ (1989) Methylphenobarbital and metharbital. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 357–378Google Scholar
  10. Evans JG, Feuerlein W, Glatt MM, Kanowski S, Scotr DB (eds) (1986) Chlormethiazole 25 years: recent developments and historical perspectives. Acta Psychiatr Scand [Suppl 329] 73 ( Deutschsprachige Ausgabe: Verlag Angew Wiss, München )Google Scholar
  11. Feldman H, Crumrine P, Handen HL, Alvin R, Teodori J (1989) Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 143: 1081–1086PubMedGoogle Scholar
  12. Fromm GH, Crumcrine P (1986) Ethosuximide: an update. In: PEDLEY TA et al. (eds) Recent advances in epilepsy. Churchill Livingstone, Edinburgh London Melbourne New York, pp 279–294Google Scholar
  13. Fuller RK (1988) Disulfiram treatment of alcoholism. In: ROSE RM, BARRET JE (eds) Alcoholism: origins and outcome. Raven, New York, pp 237–244Google Scholar
  14. Galloway SM, Farquhar DL, Munro JF (1984) The current status of antiobesity drugs. Postgrad Med J 60 [Suppl 31: 19–26Google Scholar
  15. Grant SM, Heel RC (1991) Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 41: 889–926Google Scholar
  16. Green JR, Troupin AS, Halpern LM, Triel P, Kanarek P (1974) Sulthiame: evaluation as an anticonvulsant. Epilepsia 15: 329PubMedCrossRefGoogle Scholar
  17. Kalix P (1991) The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol 32: 201–208PubMedCrossRefGoogle Scholar
  18. Kitson TM (1977) The disulfiram-ethanol reaction. J Stud Alcohol 38: 96–113PubMedGoogle Scholar
  19. Knights RM, Hinton GS (1969) The effects of methylphenidate ( Ritalin) on the motor skills and behaviour of children with learning problems. J Nery Ment Dis 148: 643–653Google Scholar
  20. Koeppen D (1985) A review of clobazam studies in epilepsy. In: Hindmarch I et al. (eds) Clobazam: human psychopharmacology and clinical applications. Royal Soc Med, London, pp 207–215Google Scholar
  21. Kovar KA (1981) D-Norpseudoephedrinhaltige Appetitzügler. Dtsch Apotheker Z 121: 18131815Google Scholar
  22. Kramer G (1989) Stellenwert der Plasmaspiegelbestimmung von Antiepileptika. Fortschr Neurol Psychiat 57: 411–424PubMedCrossRefGoogle Scholar
  23. Krämer G, Schmidt D, Stefan H, Hanefeld F (Hrsg) (1992) Vigabatrin. Akt Neurol 19: 1–58Google Scholar
  24. Kristen G, Schaefer A, V Schlichtegroll A (1986) Fenetylline. Drug Alcohol Depend 17: 259–271CrossRefGoogle Scholar
  25. Laschet U (1978) Ten years cyproterone acetate for the modification of sexual behaviour in men. BGA-Berichte 3: 91–96Google Scholar
  26. Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK (eds) (1989) Antiepileptic drugs, 3rd ed. Raven, New YorkGoogle Scholar
  27. Loiseau P (1989) Carbamazepine. Clinical use. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 533–554Google Scholar
  28. Lombroso CT, Forsythe I (1960) A long term follow-up of acetazolamid (diamox) in the treatment of epilepsy. Epilepsia 1: 493–500PubMedCrossRefGoogle Scholar
  29. Nickel B, Niebach G, Peter G, V Schlichtegroll A, Tides U (1986) Fenetylline: new results on pharmacology, metabolism and kinetics. Drug Alcohol Depend 17: 235–257PubMedCrossRefGoogle Scholar
  30. Osvaldo RE MD (1974) 2-Dimethylaminoethanol (Deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res 16: 1238–1254Google Scholar
  31. Painter MJ (1989) Phenobarbital. Clinical use. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 329–340Google Scholar
  32. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10: 241–323PubMedCrossRefGoogle Scholar
  33. Pinder RM, Brogden RN, Speight TM, Avery GS (1976) Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 12: 321–361PubMedCrossRefGoogle Scholar
  34. Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Sodium valproat: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13: 81–123PubMedCrossRefGoogle Scholar
  35. Russo ME, Covinsky JO (1983) Oxprenolol hydrochloride: pharmacology, pharmacokinetics, adverse effects and clinical efficacy. Pharmacotherapy 3: 68–81PubMedGoogle Scholar
  36. Sato S (1989) Benzodiazepines: clonazepam. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 765–784Google Scholar
  37. Schmidt D (1989) Diazepam. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 735–764Google Scholar
  38. Shorvon SD (1989) Benzodiazepines: clobazam. In: LEVY RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 821–840Google Scholar
  39. Sillanpaa M (1981) Carbamazepin. Pharmacology and clinical uses. Acta Neurol Scand [Suppl 881: 64Google Scholar
  40. Smith DB (1989) Primidone. Clinical use. In: Levy RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 423–438Google Scholar
  41. Stenzel E, Boenigk HE, Rambeck B (1977) Methsuximid in der Epilepsiebehandlung. Nervenarzt 48: 377–382PubMedGoogle Scholar
  42. Taylor SH (1983) Oxprenolol in clinical practice. Am J Cardiol 52: 34–42CrossRefGoogle Scholar
  43. Troupin AS, Ojemann LM, Dodrill CB (1976) Mephenytoin: a reappraisal. Epilepsia 17: 403–414PubMedCrossRefGoogle Scholar
  44. Tyler MW, King EQ (1951) Phenacemide in treatment of epilepsy. JAMA 147: 17–21CrossRefGoogle Scholar
  45. Wilder BJ, Rangel RJ (1989) Phenytoin. Clinical use. In: LEVY RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 233–240Google Scholar
  46. Williams DM (1990) Phenylpropanolamine hydrochloride. Am Pharm 30: 47–50CrossRefGoogle Scholar
  47. Wilson J, Walton JN, Newell DJ (1959) Beclamide in intractable epilepsy: a controlled trial. Br Med J 1: 1275PubMedCrossRefGoogle Scholar
  48. Wolf P (1991) Antiepileptika haben keinen therapeutischen Bereich. Dtsch Med Wochenschr 116: 631–633PubMedCrossRefGoogle Scholar
  49. Woodbury DM, Kemp JW (1989) Sulfonamides and derivatives: acetazolamide. In: LEVY RH et al. (eds) Antiepileptic drugs. Raven, New York, pp 855–875Google Scholar

Copyright information

© Springer-Verlag Wien 1992

Authors and Affiliations

  • O. Dietmaier
  • G. Laux

There are no affiliations available

Personalised recommendations